Brief: Microbix & Seegene Canada Form Covid-Variant Collaboration
15/03/2021 11:13
March 15 (Reuters) - Microbix Biosystems Inc MBX.TO :
* MICROBIX & SEEGENE CANADA FORM COVID-VARIANT COLLABORATION
* MICROBIX BIOSYSTEMS - SEEGENE CANADA WILL DISTRIBUTE,
RECOMMEND
CO'S NEW COVID-VARIANT QUALITY ASSESSMENT PRODUCTS
* MICROBIX BIOSYSTEMS - CO'S NOVEL COVID-VARIANT QAPS WILL
MONITOR
WORKFLOW ACCURACY AND LABORATORY TESTING PERFORMANCE OF ASSAYS
Source text for Eikon: ID:nGNXb1q51Z
Further company coverage: MBX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seegene
See all newsBrief: Seegene To Cancel 174 Billion Won Worth Of Own Shares
Brief: Seegene Q4 Operating Profit 7 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Establishes French Subsidiary To Expand European Footprint
Brief: Seegene Q2 Operating Profit 3 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Q1 Operating Profit 14.8 Billion Won, Swings To Profit From Year Earlier